XTR-006

N/A

Report date: 2024/11/04 20:00:50
NME

Base Information

Drug NameXTR-006
Drug Alias NameXTR-006
ClassificationSmall molecules > Heterocyclic drugsDiagnostic agent (In vivo)
Mechanisms of ActionPositron-emission tomography enhancersMicrotubule-associated protein tau inhibitors
TargetsMicrotubule-associated protein tau
Therapy Area/IndicationsTauopathiesAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesBeijing Xiantong International Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesBeijing Xiantong International Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsTauopathiesAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A